ReVAs: Respiratory Variations For Assessing Blood Withdrawal

Sponsor
University Hospital, Lille (Other)
Overall Status
Completed
CT.gov ID
NCT03066414
Collaborator
(none)
27
1
16
1.7

Study Details

Study Description

Brief Summary

OBJECTIVES: To investigate whether respiratory variations of the inferior vena cava (ΔIVC) and internal jugular vein (ΔIJV) diameters during standardized breathing (ΔIVCST and ΔIJVST) increase after a therapeutic bleeding in spontaneously breathing and non-obese patients with genetic hemochromatosis.

DESIGN: Prospective, monocentric study in the EFS Nord-de-France blood center.

PATIENTS: Non-obese patients with genetic hemochromatosis undergoing a therapeutic bleeding.

INTERVENTIONS: Ultrasound measures and collected clinical parameters before and after a therapeutic bleeding, during a standardized respiratory maneuver.

MAIN OUTCOME AND MEASURES: The primary endpoint was the ΔIVCST change induced by a 300 to 500ml therapeutic bleeding. It measured the minimal and maximal IVC and IJV diameters during a standardized respiratory maneuver. ΔIVCST and ΔIJVST were calculated as follows: [(maximal diameter - minimal diameter)/maximal diameter].100.

Condition or Disease Intervention/Treatment Phase
  • Procedure: echography

Study Design

Study Type:
Observational
Actual Enrollment :
27 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Respiratory Variations in Diameters of the Inferior Vena Cava and the Internal Jugular Vein to Assess Blood Withdrawal in Patients With Genetic Hemochromatosis
Study Start Date :
Feb 1, 2015
Actual Primary Completion Date :
Jun 1, 2016
Actual Study Completion Date :
Jun 1, 2016

Arms and Interventions

Arm Intervention/Treatment
non-obese patients with genetic hemochromatosis

PATIENTS: Non-obese patients with genetic hemochromatosis undergoing a therapeutic bleeding. INTERVENTIONS: The investigators performed ultrasound measurements (echography) and collected clinical parameters before and after a 300 to 500ml therapeutic bleeding, during a standardized respiratory maneuver.

Procedure: echography
The inferior vena cava and the internal jugular vein diameters were measured by echography before and after blood withdrawal during a standardized respiratory maneuver

Outcome Measures

Primary Outcome Measures

  1. blood withdrawal-induced changes in the respiratory variations of the inferior vena cava during a standardized respiratory maneuver (ΔIVCST) [during a standardized respiratory maneuver, an average 1 hour maximum]

    The primary endpoint was the ΔIVCST change induced by a 300 to 500ml therapeutic bleeding. The investigators measured the minimal and maximal IVC diameters during a standardized ventilation. ΔIVCST was calculated as follows: [(maximal diameter - minimal diameter)/maximal diameter].100.

Secondary Outcome Measures

  1. blood withdrawal-induced changes in the respiratory variations of the internal jugular vein during a standardized respiratory maneuver (ΔIJVST) [during a standardized respiratory maneuver, an average 1 hour maximum]

    The primary endpoint was the ΔIJVST change induced by a 300 to 500ml therapeutic bleeding. The investigators measured the minimal and maximal IJV diameters during a standardized ventilation. ΔIJVST was calculated as follows: [(maximal diameter - minimal diameter)/maximal diameter].100.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • adult patients of > or equal 18 years

  • genetic hemochromatosis

  • undergoing a therapeutic blood withdrawal

  • health insured

  • non-obese (body mass index <30Kg/m²)

Exclusion Criteria:
  • pregnancy

  • transthoracic echogenicity unsuitable for measuring the inferior vena cava diameters

  • clinical signs of active exhalation

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hôpital Roger Salengro, CHRU de Lille Lille France

Sponsors and Collaborators

  • University Hospital, Lille

Investigators

  • Principal Investigator: Sébastien Preau, MD, University Hospital, Lille

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Lille
ClinicalTrials.gov Identifier:
NCT03066414
Other Study ID Numbers:
  • 2013_38
  • 2013-A01689-36
First Posted:
Feb 28, 2017
Last Update Posted:
Feb 28, 2017
Last Verified:
Feb 1, 2017
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by University Hospital, Lille
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 28, 2017